6/24/26 17:10 | 6/18/26 | ADTX | Health | Drug | Pharmaceutical Preparations | Hrt Financial LP | NY | T | | P | 95 | 0.0130 | 0 | 7,340 | | 0 | D | | | | | | | | | | | | | | |
6/17/26 16:23 | 6/15/26 | ADTX | Health | Drug | Pharmaceutical Preparations | Hrt Financial LP | NY | T | | P | 30 | 0.0140 | 0 | 2,114 | | 345 | D | | | | | | | | | | | | | | |
6/16/26 09:14 | 6/12/26 | ADTX | Health | Drug | Pharmaceutical Preparations | Hrt Financial LP | NY | T | | P | 68 | 0.0160 | 0 | 4,253 | | 2,459 | D | | | | | | | | | | | | | | |
6/15/26 20:07 | 6/11/26 | ADTX | Financ | NtBnk | National Commercial Banks | Bank of America Corp /de/ | NC | T | | P | 0 | 0.0129 | 0 | 0 | 17 | 0 | I | | | | | | | | | | | | | | |
6/11/26 15:09 | 6/8/26 | ADTX | Health | Drug | Pharmaceutical Preparations | Hrt Financial LP | NY | T | | P.m | 84 | 0.0389 | 0 | 2,149 | | 1,040 | D | | | | | | | | | | | | | | |
6/8/26 18:19 | 6/4/26 | ADTX | Health | Drug | Pharmaceutical Preparations | Hrt Financial LP | NY | T | | P | 64 | 0.0760 | 0 | 844 | | 0 | D | | | | | | | | | | | | | | |
4/23/26 15:43 | 4/21/26 | ADTX | Health | Drug | Pharmaceutical Preparations | Hrt Financial LP | NY | T | | P | 24 | 0.3300 | 0 | 73 | 150 | 122 | D | | | | | | | | | | | | | | |
10/17/24 13:58 | 10/15/24 | ADTX | Health | Drug | Pharmaceutical Preparations | Hrt Financial LP | NY | T | | P | 23 | 1.50 | 0 | 16 | | 0 | D | | | | | | | | | | | | | | |
7/21/22 16:15 | 7/19/22 | ADTX | Health | Drug | Pharmaceutical Preparations | Albanna Amro A. | VA | O | CEO | P | 20 | 20,000 | 0 | 0 | New | 0 | D | | | | | | | | | | | | | | |
6/2/21 17:38 | 6/1/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Runge Jeffrey W. | CA | D | | P | 29 | 2.93 | 0 | 10 | 400 | 13 | D | | | | | | | | | | | | | | |
6/2/21 16:37 | 6/1/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Shabahang Shahrokh | CA | DO | CHIEF IN | P | 1 | 2.93 | 0 | 0 | 0 | 1,016 | I | | | | | | | | | | | | | | |
6/2/21 12:20 | 6/1/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Albanna Amro A. | CA | DO | CEO | P | 10 | 2.93 | 0 | 3 | 0 | 752 | D | | | | | | | | | | | | | | |
6/2/21 12:19 | 6/1/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Albanna Rowena | CA | O | COO | P | 10 | 2.93 | 0 | 3 | 0 | 752 | I | | | | | | | | | | | | | | |
5/28/21 18:49 | 5/25/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Shabahang Shahrokh | CA | DO | CHIEF IN | P.m | 1 | 2.49 | 0 | 1 | 0 | 2,031 | M | | | | | | | | | | | | | | |
5/27/21 13:16 | 5/26/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Farley Thomas J | CA | O | PRINCIPA | P | 7 | 2.68 | 0 | 3 | New | 3 | D | | | | | | | | | | | | | | |
5/25/21 20:03 | 5/25/21 | ADTX | Health | Drug | Pharmaceutical Preparations | Pankovcin Corinne | CA | O | CFO | P | 11 | 2.56 | 0 | 4 | 4 | 114 | D | | | | | | | | | | | | | | |